FDA Inspection
Padagis Israel Pharmaceuticals Ltd.Padagis Israel Pharmaceuticals Ltd. – FDA Inspection, Jun 13, 2019
Record Details
This FDA Inspection record concerns Padagis Israel Pharmaceuticals Ltd., with an inspection on June 13, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Mohsen Rajabi Abhari (Issuing Officer)
View Company Profile
ID · cea75258-2067-4e78-8836-6dcb7ff06d23
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1099381
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Padagis Israel Pharmaceuticals Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2023 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 27, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Padagis Israel Pharmaceuticals Ltd.
- FDA Inspection 1220679 - 2023-09-20
- FDA Inspection 1191880 - 2022-10-27
- FDA Inspection 1065389 - 2018-07-19
- FDA Inspection 910286 - 2015-01-22
- FDA Inspection 837639 - 2012-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.